BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maepa MB, Ely A, Arbuthnot P. How successful has targeted RNA interference for hepatic fibrosis been? Expert Opin Biol Ther 2018;18:381-8. [PMID: 29265946 DOI: 10.1080/14712598.2018.1420775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Joseph Naguib M, Moustafa Kamel A, Thabet Negmeldin A, Elshafeey AH, Elsayed I. Molecular docking and statistical optimization of taurocholate-stabilized galactose anchored bilosomes for the enhancement of sofosbuvir absorption and hepatic relative targeting efficiency. Drug Deliv 2020;27:996-1009. [PMID: 32611266 DOI: 10.1080/10717544.2020.1787557] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhu J, Zhang D, Wang T, Chen Z, Chen L, Wu H, Huai C, Sun J, Zhang N, Wei M, Hong F, Qin S. Target identification of hepatic fibrosis using Pien Tze Huang based on mRNA and lncRNA. Sci Rep 2021;11:16980. [PMID: 34417500 DOI: 10.1038/s41598-021-96459-5] [Reference Citation Analysis]